Market Cap 608.62M
Revenue (ttm) 0.00
Net Income (ttm) -68.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,224,600
Avg Vol 873,362
Day's Range N/A - N/A
Shares Out 54.54M
Stochastic %K 75%
Beta N/A
Analysts Strong Sell
Price Target $35.17

Latest News on BCAX

Bicara: Innovative Precision Tumor Targeting

Apr 19, 2025, 6:22 AM EDT - 6 weeks ago

Bicara: Innovative Precision Tumor Targeting


Bicara Therapeutics targets $265 mln proceeds in upsized US IPO

Sep 11, 2024, 6:34 PM EDT - 9 months ago

Bicara Therapeutics targets $265 mln proceeds in upsized US IPO


Oncology biotech Bicara Therapeutics files for a $200 million IPO

Aug 22, 2024, 5:29 PM EDT - 10 months ago

Oncology biotech Bicara Therapeutics files for a $200 million IPO


Bicara Therapeutics IPO Registration Document (S-1)

Aug 22, 2024, 4:38 PM EDT - 10 months ago

Bicara Therapeutics IPO Registration Document (S-1)